Product Category menu

Category background

Cerezyme Injection

Product Thumnail Image Zoom

[Basic Infomation]


  • South Korea South Korea
Add to My Interests Send Inquiry
Product Detail Information

 Active Ingredient
1 Vial (258mg) contains
Imiglucerase ........................212 U
Cerezyme is indicated for long term enzyme replacement therapy for pediatric and adult patients with a confirmed disgnosis of Type 1 Gaucher disease that results in one or more of the following conditions:
· anemia
· thrombocytopenia
· bone disease
· hepatomegaly or splenomegaly
· Cerezyme is administered by intravenous infusion over 1-2 hours.
· Initial dosage range from 2.5U/kg of body weight 3 times a week to 60U/kg once every two weeks. 60U/kg
  every 2 weeks is the dosage for which the most data are available. Disease severty may dictate that treatment
  be initiated at a relatively high dose or relatively frequent administration.
· Dosage adjustments should be made on an individual basis and may increase or decrease, based on
  achivement of therapeutic goals as assessed by routine comprehensive evaluations of the patient's clinical
  manifestations. General monitoring period is 6-12 months.
Genzyme Corp. (USA) 

Product Detail Image